These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. Bredella MA; Torriani M; Thomas BJ; Ghomi RH; Brick DJ; Gerweck AV; Miller KK J Clin Endocrinol Metab; 2009 Oct; 94(10):3995-4002. PubMed ID: 19602559 [TBL] [Abstract][Full Text] [Related]
31. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa. Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886 [TBL] [Abstract][Full Text] [Related]
34. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesity. Maccario M; Tassone F; Gianotti L; Lanfranco F; Grottoli S; Arvat E; Muller EE; Ghigo E J Clin Endocrinol Metab; 2001 Jan; 86(1):167-71. PubMed ID: 11231996 [TBL] [Abstract][Full Text] [Related]
35. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients. Cordido F; Alvarez-Castro P; Isidro ML; Casanueva FF; Dieguez C Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288 [TBL] [Abstract][Full Text] [Related]
36. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. Cordido F; Peñalva A; Dieguez C; Casanueva FF J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389 [TBL] [Abstract][Full Text] [Related]
37. Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men. Koutkia P; Canavan B; Breu J; Johnson ML; Grinspoon SK Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E506-12. PubMed ID: 15138154 [TBL] [Abstract][Full Text] [Related]
38. Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity. Makimura H; Stanley T; Mun D; Chen C; Wei J; Connelly JM; Hemphill LC; Grinspoon SK J Clin Endocrinol Metab; 2009 Dec; 94(12):5131-8. PubMed ID: 19837914 [TBL] [Abstract][Full Text] [Related]
39. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. Arvat E; Maccario M; Di Vito L; Broglio F; Benso A; Gottero C; Papotti M; Muccioli G; Dieguez C; Casanueva FF; Deghenghi R; Camanni F; Ghigo E J Clin Endocrinol Metab; 2001 Mar; 86(3):1169-74. PubMed ID: 11238504 [TBL] [Abstract][Full Text] [Related]
40. Regulation of pulsatile growth hormone secretion by fasting in normal subjects and patients with acromegaly. Ho PJ; Friberg RD; Barkan AL J Clin Endocrinol Metab; 1992 Sep; 75(3):812-9. PubMed ID: 1517371 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]